Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Tuesday, April 16, 2024 | Back issues
Courthouse News Service Courthouse News Service

Prescription Drugs

Shareholder claim in two federal class actions that Teva Pharmaceuticals juggled its books to appear more profitable than it was, and fixed prices, costing investors when the share price tanked.

BRIDGEPORT, Conn. — Shareholder claim in two federal class actions that Teva Pharmaceuticals juggled its books to appear more profitable than it was, and fixed prices, costing investors when the share price tanked.

Categories / Health, Securities

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...